CFDE Data Portal | Search MAGEA11

	Label	Description
	MAGEA11 associations Collection (Entity type)	Associations for MAGEA11_associations
	MAGEA11 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	MAGEA11 Gene (Entity type)	ENSG00000185247 - MAGE family member A11
	GSE82110,GSE82299 1 V 0 ACRIFLAVINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434,GSE202438 2 V 14 TALAZOPARIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE199862 Chk1 inhibition 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE152699 GSE152723 vemurafenib 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 5 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE149768 hypoxanthine 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE130956 2 V 1 ICARITIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

MAGEA11 associations

Associations for MAGEA11_associations

MAGEA11 associations.tsv

A file from IDG as part of the Harmonizome project

MAGEA11

ENSG00000185247 - MAGE family member A11

GSE82110,GSE82299 1 V 0 ACRIFLAVINE HUMAN UP

A Gene Set from LINCS

GSE202434,GSE202438 2 V 14 TALAZOPARIB HUMAN DN

A Gene Set from LINCS

GSE199862 Chk1 inhibition 3 v 1 human dn

A Gene Set from LINCS

GSE152699 GSE152723 vemurafenib 3 v 2 human up

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 5 v 6 human up

A Gene Set from LINCS

GSE149768 hypoxanthine 3 v 4 human up

A Gene Set from LINCS

GSE130956 2 V 1 ICARITIN HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.